| dc.creator |
US National Cancer Institute |
|
| dc.date |
2005-01-24T11:07:07Z |
|
| dc.date |
2005-01-24T11:07:07Z |
|
| dc.date |
2003-02-01 |
|
| dc.date |
2005-01-24T11:07:07Z |
|
| dc.date.accessioned |
2022-05-24T21:41:42Z |
|
| dc.date.available |
2022-05-24T21:41:42Z |
|
| dc.identifier |
NSC12165 |
|
| dc.identifier |
http://www.dspace.cam.ac.uk/handle/1810/16748 |
|
| dc.identifier.uri |
http://localhost:8080/xmlui/handle/CUHPOERS/130819 |
|
| dc.format |
8984 bytes |
|
| dc.format |
chemical/x-cml |
|
| dc.language |
en_GB |
|
| dc.publisher |
Unilever Center for Molecular Informatics, Cambridge University |
|
| dc.title |
NSC12165 |
|
| dc.title |
component of Halodrin |
|
| dc.title |
Androfluorene |
|
| dc.title |
Androfluorone |
|
| dc.title |
Androst-4-en-3-one, 9-fluoro-11.beta., 17.beta.-dihydroxy-17-methyl- (VAN 8CI) |
|
| dc.title |
Androst-4-en-3-one, 9-fluoro-11.beta.,17.beta.-dihydroxy-17-methyl- (VAN8CI) |
|
| dc.title |
Androst-4-en-3-one, 9-fluoro-11,17-dihydroxy-17-methyl-, (11.beta.,17.beta.)- (9CI) |
|
| dc.title |
Androsterolo |
|
| dc.title |
Fluosterone |
|
| dc.title |
Fluotestin |
|
| dc.title |
Fluoximesterone |
|
| dc.title |
Fluoxymesterone |
|
| dc.title |
Flusteron |
|
| dc.title |
Flutestos |
|
| dc.title |
FXM |
|
| dc.title |
Halotestin |
|
| dc.title |
Neo-Ormonal |
|
| dc.title |
NSC-12165 |
|
| dc.title |
Ora Testryl |
|
| dc.title |
Ora-testryl |
|
| dc.title |
Ora-Testryl |
|
| dc.title |
Oralsterone |
|
| dc.title |
Oratestin |
|
| dc.title |
Testoral |
|
| dc.title |
Testosterone, 9-fluoro-11.beta.-hydroxy-17-methyl- |
|
| dc.title |
U 6040 |
|
| dc.title |
Ultandren |
|
| dc.title |
Ultandrene |
|
| dc.title |
9.alpha.-Fluoro-11.beta.-hydroxy-17-methyltestosterone |
|
| dc.title |
9.alpha.-Fluoro-11.beta., 17.beta.-dihydroxy-17.alpha.-methyl-4-androstene-3-one |
|
| dc.type |
Chemical Structures |
|